Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 562761 - 562780 out of 563563 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA (VA) | (J07AP03) typhoid, purified polysaccharide antigen | TYPHIM VI VACCINE 20-DOSE VIAL | 1X10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUARIX (PF),SYRINGE,0.5ML 2026-27 | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUARIX (PF),SYRINGE,0.5ML 2026-27 | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUBLOK TRIVALENT 2026-27 (PF) | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLULAVAL (PF),SYRINGE,0.5ML 2026-27 | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLULAVAL (PF),SYRINGE,0.5ML 2026-27 | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUZONE 2026-27,TRIVALENT,HIGH-DOSE(PF),SYR | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUZONE TRIVALENT 2026-2027 | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUZONE TRIVALENT 2026-2027 (PF) | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | MFLUSIVA 2026-2027 | 10x0.38ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ModernaUS,Inc. |
| USA (VA) | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUAD TRI 2026-2027 (65 YR UP)(PFS) | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Influenza, Human | SeqirusUSAInc. |
| USA (VA) | (J07BC01) hepatitis b, purified antigen | HEPLISAV-B (RECOMBINANT) 20MCG/0.5ML | 5X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B | SanofiVaccinesUSInc. |
| USA (VA) | (J07BC01) hepatitis b, purified antigen | HEPLISAV-B (RECOMBINANT) 20MCG/0.5ML | 5X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B | SanofiVaccinesUSInc. |
| USA (VA) | (J07BF03) poliomyelitis, trivalent, inactivated, whole virus | IPOL 10-DOSE VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BF03) poliomyelitis, trivalent, inactivated, whole virus | IPOL 10-DOSE VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BG01) rabies, inactivated, whole virus | IMOVAX RABIES VACCINE INJ W/LL SYRINGE | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BL) yellow fever vaccines | YF-VAX 5X1DS | 5 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BL) yellow fever vaccines | YF-VAX 5X1DS | 5 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | SanofiVaccinesUSInc. |
| USA (VA) | (J07BN01) covid-19, rna-based vaccine | MNEXSPIKE 2026-2027 (12YR+) | 10X0.2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | ModernaUS,Inc. |
| USA (VA) | (J07BN01) covid-19, rna-based vaccine | SPIKEVAX 2026-2027 (6MO-11YR) | 10X0.25ML | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | ModernaUS,Inc. |
Pages
